{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-089914","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.246421+00:00","generated_at":"2026-05-31T08:57:20.727734+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Traws Pharma reports Q2 net loss of $123.1M; $16.9M cash; pipeline milestones ahead","bullets":["Net loss of $123.1M ($4.87 per share) includes $117.5M non-cash charge from acquired in-process R&D.","Cash, cash equivalents and short-term investments of $16.9M as of June 30, 2024; adequate through year-end.","Merger with Trawsfynydd completed April 2024; concurrent $14M private placement from Orbimed and Torrey Pines.","Tivoxavir marboxil (influenza) Phase 1 dose extension underway; topline results expected Q4 2024.","Ratutrelvir (COVID-19) completed Phase 1 SAD/MAD; Phase 2 initiation planned Q4 2024/Q1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-089914","json":"https://secwatch.observer/filing/0001104659-24-089914.json","markdown":"https://secwatch.observer/filing/0001104659-24-089914.md","text":"https://secwatch.observer/filing/0001104659-24-089914.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924089914/0001104659-24-089914-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924089914/tm2421727d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:57:20.727734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}